Walker PR - Search Results

1

Identification of a miRNA multi-targeting therapeutic strategy in glioblastoma.

Bassot A, Dragic H, Haddad SA, Moindrot L, Odouard S, Corlazzoli F, Marinari E, Bomane A, Brassens A, Marteyn A, Hibaoui Y, Petty TJ, Chalabi-Dchar M, Larrouquere L, Zdobnov EM, Legrand N, Tamburini J, Lincet H, Castets M, Yebra M, Migliorini D, Dutoit V, Walker PR, Preynat-Seauve O, Dietrich PY, Cosset É. Bassot A, et al. Among authors: walker pr. Cell Death Dis. 2023 Sep 25;14(9):630. doi: 10.1038/s41419-023-06117-z. Cell Death Dis. 2023. PMID: 37749143 Free PMC article.

2

Fas ligand expression by astrocytoma in vivo: maintaining immune privilege in the brain?

Saas P, Walker PR, Hahne M, Quiquerez AL, Schnuriger V, Perrin G, French L, Van Meir EG, de Tribolet N, Tschopp J, Dietrich PY. Saas P, et al. Among authors: walker pr. J Clin Invest. 1997 Mar 15;99(6):1173-8. doi: 10.1172/JCI119273. J Clin Invest. 1997. PMID: 9077524 Free PMC article.

3

Role of Fas ligand (CD95L) in immune escape: the tumor cell strikes back.

Walker PR, Saas P, Dietrich PY. Walker PR, et al. J Immunol. 1997 May 15;158(10):4521-4. J Immunol. 1997. PMID: 9144461 Review.

4

Immunobiology of gliomas: new perspectives for therapy.

Dietrich PY, Walker PR, Saas P, de Tribolet N. Dietrich PY, et al. Among authors: walker pr. Ann N Y Acad Sci. 1997 Sep 17;824:124-40. doi: 10.1111/j.1749-6632.1997.tb46215.x. Ann N Y Acad Sci. 1997. PMID: 9382437 Review. No abstract available.

5

Tumor expression of Fas ligand (CD95L) and the consequences.

Walker PR, Saas P, Dietrich PY. Walker PR, et al. Curr Opin Immunol. 1998 Oct;10(5):564-72. doi: 10.1016/s0952-7915(98)80225-2. Curr Opin Immunol. 1998. PMID: 9794830 Review.

6

CD95 (Fas/Apo-1) as a receptor governing astrocyte apoptotic or inflammatory responses: a key role in brain inflammation?

Saas P, Boucraut J, Quiquerez AL, Schnuriger V, Perrin G, Desplat-Jego S, Bernard D, Walker PR, Dietrich PY. Saas P, et al. Among authors: walker pr. J Immunol. 1999 Feb 15;162(4):2326-33. J Immunol. 1999. PMID: 9973511

7

Astrocytoma infiltrating lymphocytes include major T cell clonal expansions confined to the CD8 subset.

Perrin G, Schnuriger V, Quiquerez AL, Saas P, Pannetier C, de Tribolet N, Tiercy JM, Aubry JP, Dietrich PY, Walker PR. Perrin G, et al. Among authors: walker pr. Int Immunol. 1999 Aug;11(8):1337-50. doi: 10.1093/intimm/11.8.1337. Int Immunol. 1999. PMID: 10421791

8

The brain parenchyma is permissive for full antitumor CTL effector function, even in the absence of CD4 T cells.

Walker PR, Calzascia T, Schnuriger V, Scamuffa N, Saas P, de Tribolet N, Dietrich PY. Walker PR, et al. J Immunol. 2000 Sep 15;165(6):3128-35. doi: 10.4049/jimmunol.165.6.3128. J Immunol. 2000. PMID: 10975826

9

TWEAK stimulation of astrocytes and the proinflammatory consequences.

Saas P, Boucraut J, Walker PR, Quiquerez AL, Billot M, Desplat-Jego S, Chicheportiche Y, Dietrich PY. Saas P, et al. Among authors: walker pr. Glia. 2000 Oct;32(1):102-7. Glia. 2000. PMID: 10975915

10

Loss of Fas (CD95/APO-1) expression by antigen-specific cytotoxic T cells is reversed by inhibiting DNA methylation.

Walker PR, Calzascia T, Schnuriger V, Chalmers D, Saas P, Dietrich PY. Walker PR, et al. Cell Immunol. 2000 Nov 25;206(1):51-8. doi: 10.1006/cimm.2000.1722. Cell Immunol. 2000. PMID: 11161437

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

249 results

Search Page